Global  

Coronavirus Vaccines: R&D Landscape – Analysis

Eurasia Review Monday, 7 September 2020
Coronavirus Vaccines: R&D Landscape – AnalysisScientists edge closer to develop a vaccine against the SARS-CoV-2 corona virus and Indian pharmaceutical companies are in front and centre of the race to supply the world with an effective product. However India’s experience as a vaccine manufacturer, its companies have to struggle to produce enough doses sufficiently fast to...
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Johnson & Johnson Begins Late-Stage Coronavirus Vaccine Trial [Video]

Johnson & Johnson Begins Late-Stage Coronavirus Vaccine Trial

Coronavirus deaths have surpassed 206,000 in the U.S as the world awaits a vaccine. Business Inisder reports that Johnson & Johnson has started a late-stage trial for its coronavirus vaccine. The..

Credit: Wochit Business     Duration: 00:32Published
Indians return from Pakistan: 400 people stranded amid Covid lockdown back [Video]

Indians return from Pakistan: 400 people stranded amid Covid lockdown back

Around 400 people reportedly returned from Pakistan to India via the Wagah-Attari border crossing. They were stuck in the neighbouring nation due to the Covid-19 pandemic and the consequent lockdown...

Credit: HT Digital Content     Duration: 03:00Published
China: COVID-19 vaccine will be available by November [Video]

China: COVID-19 vaccine will be available by November

Hundreds of thousands of Chinese have already been injected with experimental vaccines.

Credit: Al Jazeera STUDIO     Duration: 02:26Published